John Rim, Samsung Biologics CEO

Sam­sung’s CD­MO arm com­mits to $324M land pur­chase for a sec­ond bio cam­pus

As in­vest­ments in­to CD­MOs are gain­ing steam from sev­er­al South Ko­re­an and Japan­ese con­glom­er­ates, Sam­sung is mak­ing a big land grab.

On Mon­day, Sam­sung Bi­o­log­ics, the CD­MO arm of the Ko­re­an con­glom­er­ate, an­nounced that it has of­fi­cial­ly signed a land pur­chase agree­ment with the In­cheon Free Eco­nom­ic Zone to sup­port the build-out of its sec­ond bio cam­pus, dubbed Bio Cam­pus II. Sam­sung stat­ed that the 3.8 mil­lion square foot land pur­chase is val­ued at about $324 mil­lion. The land, which is lo­cat­ed with­in the Song­do In­dus­tri­al Clus­ter, will be 30% larg­er than the com­pa­ny’s cur­rent cam­pus.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.